Kezar Ebit Per Revenue vs Capex To Revenue Analysis

KZR Stock

USD 6.33 0.14 2.26%

Kezar Life financial indicator trend analysis is infinitely more than just investigating Kezar Life Sciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kezar Life Sciences is a good investment. Please check the relationship between Kezar Life Ebit Per Revenue and its Capex To Revenue accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kezar Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Ebit Per Revenue vs Capex To Revenue

Ebit Per Revenue vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Kezar Life Sciences Ebit Per Revenue account and Capex To Revenue. At this time, the significance of the direction appears to have pay attention.

The correlation between Kezar Life's Ebit Per Revenue and Capex To Revenue is -0.84. Overlapping area represents the amount of variation of Ebit Per Revenue that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Kezar Life Sciences, assuming nothing else is changed. The correlation between historical values of Kezar Life's Ebit Per Revenue and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit Per Revenue of Kezar Life Sciences are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Ebit Per Revenue i.e., Kezar Life's Ebit Per Revenue and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

-0.84

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Ebit Per Revenue

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from Kezar Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kezar Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kezar Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

As of 01/22/2025, Selling General Administrative is likely to grow to about 32 M, though Issuance Of Capital Stock is likely to grow to (200.1 K).

Kezar Life fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Preferred Stock Total Equity	Total Current Assets
Total Assets		0.8	0.81	0.99	0.88	0.93	0.94	-0.38	-0.89	0.66	0.75	0.87	0.57	0.85	1.0	0.71	0.93	0.87	-0.43	0.92	0.92	0.9	-0.15	0.97	0.83	1.0
Other Current Liab	0.8		0.96	0.78	0.79	0.94	0.7	-0.29	-0.93	0.94	0.64	0.9	0.91	0.92	0.8	0.83	0.92	0.92	-0.35	0.94	0.69	0.92	-0.1	0.78	0.63	0.8
Total Current Liabilities	0.81	0.96		0.79	0.81	0.95	0.79	-0.16	-0.97	0.96	0.58	0.97	0.93	0.95	0.81	0.91	0.95	0.97	-0.38	0.96	0.76	0.97	-0.12	0.84	0.63	0.81
Total Stockholder Equity	0.99	0.78	0.79		0.9	0.93	0.95	-0.29	-0.87	0.63	0.68	0.86	0.53	0.81	0.99	0.67	0.92	0.84	-0.56	0.91	0.9	0.89	-0.3	0.96	0.8	0.99
Other Liab	0.88	0.79	0.81	0.9		0.9	0.89	-0.31	-0.81	0.66	0.63	0.88	0.59	0.81	0.87	0.61	0.88	0.78	-0.6	0.88	0.7	0.84	-0.39	0.84	0.88	0.87
Net Tangible Assets	0.93	0.94	0.95	0.93	0.9		0.89	-0.24	-0.97	0.85	0.65	0.97	0.79	0.93	0.93	0.84	0.99	0.96	-0.5	1.0	0.85	0.98	-0.24	0.92	0.72	0.93
Property Plant And Equipment Net	0.94	0.7	0.79	0.95	0.89	0.89		-0.17	-0.84	0.61	0.57	0.9	0.53	0.84	0.93	0.74	0.87	0.81	-0.51	0.88	0.9	0.86	-0.25	0.97	0.81	0.94
Net Debt	-0.38	-0.29	-0.16	-0.29	-0.31	-0.24	-0.17		0.2	-0.08	-0.87	-0.13	-0.05	-0.29	-0.39	0.03	-0.26	-0.21	-0.37	-0.24	-0.14	-0.21	-0.47	-0.21	-0.57	-0.39
Retained Earnings	-0.89	-0.93	-0.97	-0.87	-0.81	-0.97	-0.84	0.2		-0.91	-0.63	-0.96	-0.85	-0.93	-0.89	-0.89	-0.97	-0.98	0.39	-0.98	-0.85	-0.98	0.1	-0.91	-0.66	-0.89
Accounts Payable	0.66	0.94	0.96	0.63	0.66	0.85	0.61	-0.08	-0.91		0.46	0.89	0.99	0.88	0.65	0.9	0.86	0.91	-0.27	0.87	0.64	0.89	-0.03	0.7	0.47	0.65
Cash	0.75	0.64	0.58	0.68	0.63	0.65	0.57	-0.87	-0.63	0.46		0.56	0.4	0.67	0.76	0.4	0.67	0.63	0.09	0.66	0.56	0.64	0.31	0.64	0.77	0.76
Non Current Assets Total	0.87	0.9	0.97	0.86	0.88	0.97	0.9	-0.13	-0.96	0.89	0.56		0.84	0.97	0.86	0.91	0.95	0.94	-0.44	0.97	0.82	0.97	-0.17	0.91	0.71	0.87
Non Currrent Assets Other	0.57	0.91	0.93	0.53	0.59	0.79	0.53	-0.05	-0.85	0.99	0.4	0.84		0.85	0.56	0.88	0.78	0.84	-0.21	0.8	0.54	0.82	0.02	0.62	0.42	0.56
Other Assets	0.85	0.92	0.95	0.81	0.81	0.93	0.84	-0.29	-0.93	0.88	0.67	0.97	0.85		0.85	0.92	0.92	0.92	-0.21	0.94	0.8	0.93	0.05	0.87	0.73	0.85
Cash And Short Term Investments	1.0	0.8	0.81	0.99	0.87	0.93	0.93	-0.39	-0.89	0.65	0.76	0.86	0.56	0.85		0.7	0.93	0.87	-0.42	0.92	0.92	0.9	-0.15	0.96	0.82	1.0
Net Receivables	0.71	0.83	0.91	0.67	0.61	0.84	0.74	0.03	-0.89	0.9	0.4	0.91	0.88	0.92	0.7		0.84	0.9	-0.2	0.87	0.8	0.89	0.05	0.79	0.46	0.7
Common Stock Total Equity	0.93	0.92	0.95	0.92	0.88	0.99	0.87	-0.26	-0.97	0.86	0.67	0.95	0.78	0.92	0.93	0.84		0.98	-0.47	1.0	0.87	0.99	-0.21	0.91	0.71	0.93
Common Stock Shares Outstanding	0.87	0.92	0.97	0.84	0.78	0.96	0.81	-0.21	-0.98	0.91	0.63	0.94	0.84	0.92	0.87	0.9	0.98		-0.36	0.98	0.86	0.99	-0.1	0.87	0.6	0.87
Non Current Liabilities Total	-0.43	-0.35	-0.38	-0.56	-0.6	-0.5	-0.51	-0.37	0.39	-0.27	0.09	-0.44	-0.21	-0.21	-0.42	-0.2	-0.47	-0.36		-0.46	-0.35	-0.41	0.95	-0.45	-0.27	-0.42
Capital Surpluse	0.92	0.94	0.96	0.91	0.88	1.0	0.88	-0.24	-0.98	0.87	0.66	0.97	0.8	0.94	0.92	0.87	1.0	0.98	-0.46		0.86	0.99	-0.2	0.92	0.7	0.92
Other Current Assets	0.92	0.69	0.76	0.9	0.7	0.85	0.9	-0.14	-0.85	0.64	0.56	0.82	0.54	0.8	0.92	0.8	0.87	0.86	-0.35	0.86		0.86	-0.08	0.93	0.63	0.92
Other Stockholder Equity	0.9	0.92	0.97	0.89	0.84	0.98	0.86	-0.21	-0.98	0.89	0.64	0.97	0.82	0.93	0.9	0.89	0.99	0.99	-0.41	0.99	0.86		-0.15	0.91	0.66	0.9
Total Liab	-0.15	-0.1	-0.12	-0.3	-0.39	-0.24	-0.25	-0.47	0.1	-0.03	0.31	-0.17	0.02	0.05	-0.15	0.05	-0.21	-0.1	0.95	-0.2	-0.08	-0.15		-0.16	-0.03	-0.15
Property Plant And Equipment Gross	0.97	0.78	0.84	0.96	0.84	0.92	0.97	-0.21	-0.91	0.7	0.64	0.91	0.62	0.87	0.96	0.79	0.91	0.87	-0.45	0.92	0.93	0.91	-0.16		0.78	0.96
Preferred Stock Total Equity	0.83	0.63	0.63	0.8	0.88	0.72	0.81	-0.57	-0.66	0.47	0.77	0.71	0.42	0.73	0.82	0.46	0.71	0.6	-0.27	0.7	0.63	0.66	-0.03	0.78		0.82
Total Current Assets	1.0	0.8	0.81	0.99	0.87	0.93	0.94	-0.39	-0.89	0.65	0.76	0.87	0.56	0.85	1.0	0.7	0.93	0.87	-0.42	0.92	0.92	0.9	-0.15	0.96	0.82

Click cells to compare fundamentals

Kezar Life Account Relationship Matchups

Kezar Life fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	151.8M	217.9M	299.6M	221.2M	254.4M	159.6M
Other Current Liab	2M	3.8M	3.4M	6.5M	7.5M	7.8M
Total Current Liabilities	6.4M	8.2M	11.0M	17.7M	20.4M	21.4M
Total Stockholder Equity	141.0M	196.9M	269.9M	187.6M	215.7M	129.1M
Net Tangible Assets	78.0M	141.0M	196.9M	269.9M	310.4M	325.9M
Property Plant And Equipment Net	6.7M	6.0M	13.2M	8.7M	10.0M	6.8M
Net Debt	(15.8M)	(48.8M)	(19.2M)	(16.6M)	(19.0M)	(20.0M)
Retained Earnings	(126.0M)	(180.7M)	(248.9M)	(350.8M)	(315.7M)	(299.9M)
Accounts Payable	2.4M	2.0M	2.5M	8.3M	9.5M	10.0M
Cash	21.2M	62.9M	40.5M	35.5M	40.8M	35.7M
Non Current Assets Total	7.0M	6.3M	13.8M	14.3M	16.4M	17.2M
Cash And Short Term Investments	140.4M	208.4M	276.6M	201.4M	231.6M	147.6M
Net Receivables	642K	766K	70K	2.3M	2.6M	2.8M
Common Stock Shares Outstanding	44.0M	52.8M	67.4M	72.6M	83.4M	87.6M
Liabilities And Stockholders Equity	151.8M	217.9M	299.6M	221.2M	254.4M	159.6M
Non Current Liabilities Total	4.4M	12.8M	18.7M	15.9M	14.3M	16.7M
Capital Surpluse	162.5M	267.1M	377.8M	519.6M	597.6M	627.4M
Other Current Assets	4.4M	3.3M	9.2M	5.6M	6.4M	3.4M
Other Stockholder Equity	267.1M	377.8M	519.6M	538.4M	619.1M	650.1M
Total Liab	10.9M	21.1M	29.7M	33.7M	30.3M	22.1M
Property Plant And Equipment Gross	6.7M	9.6M	17.8M	14.1M	16.2M	8.7M
Total Current Assets	144.8M	211.7M	285.7M	207.0M	238.0M	151.6M
Accumulated Other Comprehensive Income	(137K)	(291K)	(923K)	(130K)	(117K)	(122.9K)
Common Stock	46K	56K	68K	73K	84.0K	88.1K
Property Plant Equipment	8.1M	3.4M	3.3M	3.4M	3.9M	4.0M
Net Invested Capital	141.0M	206.5M	279.7M	197.6M	227.3M	154.9M
Net Working Capital	138.4M	203.4M	274.7M	189.2M	217.6M	163.1M
Retained Earnings Total Equity	(84.3M)	(126.0M)	(180.7M)	(248.9M)	(224.0M)	(212.8M)
Short Term Investments	119.2M	145.5M	236.1M	165.9M	190.8M	149.1M
Capital Stock	46K	56K	68K	73K	84.0K	51.5K
Short Long Term Debt Total	5.5M	14.0M	21.3M	18.9M	21.8M	14.5M
Capital Lease Obligations	5.5M	4.4M	11.4M	8.9M	10.2M	8.0M
Short Term Debt	2.1M	2.4M	5.1M	3.0M	3.5M	3.0M

Pair Trading with Kezar Life

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kezar Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will appreciate offsetting losses from the drop in the long position's value.

Moving together with Kezar Stock

0.65	AZN	AstraZeneca PLC ADR	Pair Corr
0.8	GSK	GlaxoSmithKline PLC ADR	Pair Corr
0.61	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.88	NVS	Novartis AG ADR	Pair Corr

Moving against Kezar Stock

0.69	MBFJF	Mitsubishi UFJ Financial	Pair Corr
0.6	GILD	Gilead Sciences	Pair Corr
0.37	LH	Laboratory	Pair Corr

The ability to find closely correlated positions to Kezar Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kezar Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kezar Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kezar Life Sciences to buy it.

The correlation of Kezar Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kezar Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kezar Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Kezar Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Kezar Stock Analysis

When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC